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Most animals are diploid but in several cases haploid
genomes can support development to some extent. In
contrast to fish, haploidy is not compatible with embryo-
nic development in mammals. Albeit, haploid cells have
been observed in egg cylinder stage mouse embryos the
majority of surviving embryos becomes diploid. Differ-
ences between the development of mammals and fish
include genomic imprinting and dosage compensation.
Both processes are thought to contribute to the loss of
haploid embryos.
Haploid embryonic stem cells (ESCs) have recently been
derived from mouse parthenogenetic embryos. These cells
maintain key properties of mouse ESCs and might over-
come existing limitations in developmental genetic
approaches in mice. Haploid ESCs have been established
through the activation of unfertilized oocytes from a vari-
ety of mouse strains and maintain a wide developmental
potential in culture and in chimeric mice. Notably, parthe-
nogenetic haploid ESCs possess robust germline compe-
tence enabling the production of transgenic mouse strains
from genetically modified haploid ESCs. Contribution to
the embryo correlates with an efficient gain of a diploid
karyotype. We have also observed that differentiation in
culture results in diploidization, which likely is the result
of endoreduplication and not cell fusion. In contrast to dif-
ferentiation into embryonic cell types a haploid karyotype
is maintained under certain conditions during forced dif-
ferentiation to extraembryonic cell fates.
Exploring the differentiation potential of a haploid kar-
yotype highlights developmental constraints imposed by
evolutionary adaptations specific for the mammalian gen-
ome namely genomic imprinting and X chromosome
inactivation. Our data would suggest that early embryos
possess a remarkable ability to buffer disturbances of
both epigenetic processes.
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